Advisor Group’s AIM ImmunoTech AIM Stock Holding History

Advisor Group’s Portfolio AIM Stock Details AIM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Hold	0	–	–	–	5679
2019 Q3	–	Hold	0	–	–	–	5639
2019 Q2	–	Sell	-1	Closed	-$605	–	5579
2019 Q1	$0	Buy	+1	New	+$890	﹤0.01%	5540
2018 Q4	–	Hold	0	–	–	–	5482
2018 Q3	–	Hold	0	–	–	–	5438
2018 Q2	–	Hold	0	–	–	–	5277
2018 Q1	–	Hold	0	–	–	–	5271
2017 Q4	–	Hold	0	–	–	–	5275
2017 Q3	–	Hold	0	–	–	–	5174
2017 Q2	–	Hold	0	–	–	–	5119
2017 Q1	–	Hold	0	–	–	–	5004

Other funds holding AIM

Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

APA

American Portfolios Advisors Holbrook, New York $2.36B AUM 14.59% 1-Year Est. Return

Advisor Group's AIM Position: Q4 2019 in Review

Advisor Group held its AIM ImmunoTech (AIM) position steady in Q4 2019 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #5679.

Advisor Group first reported a position in AIM in Q1 2019 and has held it in 1 quarter since. The position peaked at $0 in Q1 2019. 9 funds tracked by Wall St. Rank hold AIM as of Q4 2019.

Advisor Group held 0 shares of AIM ImmunoTech worth $0 as of Q4 2019.
Advisor Group left its AIM ImmunoTech share count unchanged in Q4 2019.
AIM ImmunoTech made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #5679 holding.
Advisor Group first reported a position in AIM ImmunoTech in Q1 2019 and has held it in 1 quarter since.
Advisor Group's AIM ImmunoTech position peaked at $0 in Q1 2019.
9 funds tracked by Wall St. Rank held AIM ImmunoTech as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.